Evaluation of monoclonal humanized anti-HER2 antibody,trastuzumab,in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2:a phase II trial of the Gynecologic Oncology Group

查看全文 作　　者：Bookman MA;Darcy KM;Clarke-Pearson D; 出　　处：《J Clin Oncol》索引2003年第21卷第2期,共0页